Imaging Contrast Dye Shortage Delays Tests for Diseases

Many U.S. hospitals are postponing scans used to diagnose diseases after a Covid lockdown in China hobbled the main U.S. supplier of an imaging chemical.

View original article
Contributor: Reed Abelson